Drugs / Sodium Caprate
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT05794243 Background | Mar → Jun 2023 | — | Eli Lilly and Company | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sodium Caprate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05794243 ↗ |
| Known as | C10 | “Drug: Sodium Caprate (C10)” NCT05794243 ↗ |
| Route | Oral | “Administered orally.” NCT05794243 ↗ |